For research use only. Not for therapeutic Use.
Lopixibat chloride（Cat No.:I007690）is a selective inhibitor of the ileal bile acid transporter (IBAT), designed to treat conditions related to bile acid malabsorption, such as bile acid diarrhea and certain cholestatic liver diseases. By inhibiting IBAT, Lopixibat reduces the reabsorption of bile acids in the intestines, lowering bile acid levels in the bloodstream and decreasing associated symptoms like diarrhea and liver damage. Its targeted action on bile acid transport offers a potential therapeutic approach for managing gastrointestinal and liver disorders that involve bile acid dysregulation, improving patient outcomes.
| Catalog Number | I007690 |
| CAS Number | 228113-66-4 |
| Synonyms | LUM-001; LUM001; LUM 001; SHP-625; SHP 625; SHP625; Lopixibat chloride;1-(4-((4-((4R,5R)-3,3-dibutyl-7-(dimethylamino)-4-hydroxy-1,1-dioxido-2,3,4,5-tetrahydrobenzo[b]thiepin-5-yl)phenoxy)methyl)benzyl)-1,4-diazabicyclo[2.2.2]octan-1-ium chloride |
| Molecular Formula | C40H56ClN3O4S |
| Purity | 98% |
| Target | Apical Sodium-Dependent Bile Acid Transporter |
| Target Protein | Q12908 |
| Solubility | Soluble in DMSO, not in water |
| Appearance | Solid |
| Storage | Dry, dark and at 2 - 8 °C for six months or -20°C for two years. |
| IUPAC Name | (4R,5R)-5-[4-[[4-(4-aza-1-azoniabicyclo[2.2.2]octan-1-ylmethyl)phenyl]methoxy]phenyl]-3,3-dibutyl-7-(dimethylamino)-1,1-dioxo-4,5-dihydro-2H-1lambda6-benzothiepin-4-ol;chloride |
| InChI | InChI=1S/C40H56N3O4S.ClH/c1-5-7-19-40(20-8-6-2)30-48(45,46)37-18-15-34(41(3)4)27-36(37)38(39(40)44)33-13-16-35(17-14-33)47-29-32-11-9-31(10-12-32)28-43-24-21-42(22-25-43)23-26-43;/h9-18,27,38-39,44H,5-8,19-26,28-30H2,1-4H3;1H/q+1;/p-1/t38-,39-;/m1./s1 |
| InChIKey | POMVPJBWDDJCMP-RUKDTIIFSA-M |
| SMILES | CCCCC1(CS(=O)(=O)C2=C(C=C(C=C2)N(C)C)[C@H]([C@H]1O)C3=CC=C(C=C3)OCC4=CC=C(C=C4)C[N+]56CCN(CC5)CC6)CCCC.[Cl-] |
| Reference | </br>1:The possibility of using C<sub>20</sub> fullerene and graphene as semiconductor segments for detection, and destruction of cyanogen-chloride chemical agent. Pakravan P, Siadati SA.J Mol Graph Model. 2017 Apr 27;75:80-84. doi: 10.1016/j.jmgm.2016.12.001. [Epub ahead of print] PMID: 28521282 </br>2:Functional Assessment of Sodium Chloride Co-transporter NCC Mutants in Polarized Mammalian Epithelial Cells. Rosenbaek LL, Rizzo F, MacAulay N, Staub O, Fenton RA.Am J Physiol Renal Physiol. 2017 May 17:ajprenal.00088.2017. doi: 10.1152/ajprenal.00088.2017. [Epub ahead of print] PMID: 28515174 </br>3:Hypericum perforatum extract attenuates behavioral, biochemical, and neurochemical abnormalities in Aluminum chloride-induced Alzheimer/’s disease rats. Cao Z, Wang F, Xiu C, Zhang J, Li Y.Biomed Pharmacother. 2017 May 13;91:931-937. doi: 10.1016/j.biopha.2017.05.022. [Epub ahead of print] PMID: 28514831 </br>4:Influence of addition of [2-(methacryloyloxy)ethyl]trimethylammonium chloride to an experimental adhesive. Collares FM, Leitune VCB, Franken P, Parollo CF, Ogliari FA, Samuel SMW.Braz Oral Res. 2017 May 4;31:e31. doi: 10.1590/1807-3107BOR-2017.vol31.0031. PMID: 28513783 Free Article</br>5:Development of In Vitro-In Vivo Correlation for Potassium Chloride Extended Release Tablet Formulation Using Urinary Pharmacokinetic Data. Mittapalli RK, Marroum P, Qiu Y, Apfelbaum K, Xiong H.Pharm Res. 2017 May 16. doi: 10.1007/s11095-017-2179-2. [Epub ahead of print] PMID: 28512718 </br>6:[Influence of aluminum chloride exposure on embryonic development of zebrafish and neurobehavior of juvenile fish]. Chen JP, Shang N, He KH, Zhang L, Niu Q, Zhang QL.Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi. 2017 Mar 20;35(3):166-170. doi: 10.3760/cma.j.issn.1001-9391.2017.03.002. Chinese. PMID: 28511298 </br>7:Familial Hyperkalemia and Hypertension (FHHt) and KLHL3: Description of a Family with a New Recessive Mutation (S553L) Compared to a Family with a Dominant Mutation, Q309R, with Analysis of Urinary Sodium Chloride Cotransporter. Kliuk-Ben Bassat O, Carmon V, Hanukoglu A, Ganon L, Massalha E, Holtzman EJ, Farfel Z, Mayan H.Nephron. 2017 May 17. doi: 10.1159/000475825. [Epub ahead of print] PMID: 28511177 </br>8:Chloride-accelerated Cu-Fenton chemistry for biofilm removal. Wang L, Miao Y, Lu M, Shan Z, Lu S, Hou J, Yang Q, Liang X, Zhou T, Curry D, Oakes K, Zhang X.Chem Commun (Camb). 2017 May 16. doi: 10.1039/c7cc00928c. [Epub ahead of print] PMID: 28508904 </br>9:From polyethylene waxes to HDPE using an α,α/’-bis(arylimino)-2,3:5,6-bis(pentamethylene)pyridyl-chromium(iii) chloride pre-catalyst in ethylene polymerisation. Huang C, Du S, Solan GA, Sun Y, Sun WH.Dalton Trans. 2017 May 16. doi: 10.1039/c7dt01077j. [Epub ahead of print] PMID: 28508901 </br>10:Publisher/’s Note: Effect of the salt-induced micellar microstructure on the nonlinear shear flow behavior of ionic cetylpyridinium chloride surfactant solutions [Phys. Rev. E 95, 032603 (2017)]. Gaudino D, Pasquino R, Kriegs H, Szekely N, Pyckhout-Hintzen W, Lettinga MP, Grizzuti N.Phys Rev E. 2017 Apr;95(4-2):049902. doi: 10.1103/PhysRevE.95.049902. Epub 2017 Apr 26. PMID: 28505808 |
